Keith Wayne Ward - 14 Dec 2021 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol
SKYE
Transactions as of
14 Dec 2021
Net transactions value
$0
Form type
3
Filing time
16 Dec 2021, 17:43:52 UTC
Next filing
09 Jan 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney.